The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats

Psychopharmacology

Volumn 179, Issue 1, 2005, Pages 255-261

  Paterson, Neil E ^a   Markou, Athina ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cocaine; Extinction; Food; Glutamate; mGlu5 receptors; MPEP; Nicotine; Progressive ratio; Rat; Self administration

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; COCAINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 5 ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NICOTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; FOOD; LATIN SQUARE DESIGN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD;

ANIMALS; COCAINE; EXCITATORY AMINO ACID ANTAGONISTS; FOOD; MALE; MOTIVATION; NICOTINE; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 17744383991     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2070-9     Document Type: Article

References (48)

1. Arnold JM, Roberts DCS (1997) A critique of fixed and progressive-ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57(3):441-447
2. Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R (2004) mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology [Epub ahead of print Jan 21]
3. Balfour DJ, Wright AE, Benwell ME, Birrell CE (2000) The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113(1-2):73-83
4. Bindra D (1976) A theory of intelligent behavior. Wiley, New York
5. B agonist CGP44532 decreases cocaine self-administration in rats: demonstration using a progressive-ratio and a discrete trials procedure. Neuropharmacology 38:1797-1804
6. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins ICA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515-530
7. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270(1):209-218
8. Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6(4):333-347
9. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4(9):873-874
10. Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104: 171-176
11. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75(2):134-143
12. Dews PB (1955) Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther 138:393-401
13. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive-ratio schedule of reinforcement. Psychopharmacology 147:135-142
14. Donny EC, Caggiula AR, Rose C, Jacobs KS, Mielke MM, Sved AF (2000) Differential effects of response-contingent and response-independent nicotine in rats. Eur J Pharmacol 402(3):231-240
15. Droungas A, Ehrman RN, Childress AR, O'Brien CP (1995) Effects of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav 20:657-673
16. Due DL, Huettel SA, Hall WG, Rubin DC (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954-960
17. Dworkin SI, Mirkis S, Smith JE (1995) Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117(3):262-266
18. Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37(5):495-498
19. Gardner EL (2000) What we have learned about addiction from animal models of drug self-administration. Am J Addict 9 (4):285-313
20. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-Methyl-6- (phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493-1503
21. 1B/1D antagonist. Psychopharmacology 141:242-250
22. Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology 160:56-66
23. Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A (2002) The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 43(8):1199-1209
24. 1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15(7 Pt 2):5379-5388
25. Kenny PJ, Gasparini F, Markou A (2003) Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306(3):1068-1076
26. Koob GF (2003) Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 13: 442-452
27. Levin ED, Mead T, Rezvani AH, Rose JE, Gallivan C, Gross R (2000) The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav 71(5):565-570
28. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163-182
29. Markou A, Arroyo M, Everitt BJ (1999) Effects of contingent and non-contingent cocaine on drug-seeking behavior measured using a second-order schedule of cocaine reinforcement in rats. Neuropsychopharmacology 20:542-555
30. McGeehan AJ, Olive MF (2003) The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47(3):240-242
31. McMillan DE, Katz JL (2002) Continuing implications of the early evidence against the drive reduction hypothesis of the behavioral effects of drugs. Psychopharmacology 163(3-4): 251-264
32. National Institutes of Health (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington D.C.
33. Paterson NE, Markou A (2003) Increased motivation for self-administered cocaine after escalated cocaine intake. NeuroReport 14(17):2229-2232
34. Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluRS antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167(3):257-264
35. Paterson NE, Froestl W, Markou A (2004a) The GABA(B) receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172(2):179-186
36. Paterson NE, Froestl W, Markou A (2004b) Repeated administration of the GABA(B) receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology. Online publication Jul 21 2004. DOI: 10.1038/sj.npp.1300524
37. 2 subunit are involved in the reinforcing properties of nicotine. Nature 391(6663):173-177
38. Popik P, Wrobel M (2002) Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43(8): 1210-1217
39. Reid MS, Hsu K Jr, Berger SP (1997) Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27(2):95-105
40. Reid MS, Fox L, Ho LB, Berger SP (2000) Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Synapse 35(2):129-136
41. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39(1): 32-41
42. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH (2000) Putative role of presynaptic alpha*7 nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38(4):375-383
43. Stafford D, LeSAge MG, Glowa JR (1999) Effects of phentermine on responding maintained by progressive ratio schedules of cocaine and food delivery in rhesus monkeys. Behav Pharmacol 10(8):775-784
44. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001) Potential anxiolytic- and anti-depressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132:1423-1430
45. Watkins SS, Epping-Jordan MP, Koob GF, Markou A (1999) Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62(4):743-751
46. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
47. Wojnicki FH, Rothman RB, Rice KC, Glowa JR (1999) Effect of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey. J Pharmacol Exp Ther 288(2):550-560
48. 2 dopamine antagonist on the self-administration of cocaine and pirebedil by rhesus monkeys. Pharmacol Biochem Behav 24(3):531-535